Renovaro Inc. (RENB)
NASDAQ: RENB · Real-Time Price · USD
0.5788
-0.0707 (-10.89%)
At close: Mar 28, 2025, 4:00 PM
0.5918
+0.0130 (2.24%)
After-hours: Mar 28, 2025, 7:55 PM EDT
Renovaro Employees
Renovaro had 25 employees as of June 30, 2024. The number of employees increased by 13 or 108.33% compared to the previous year.
Employees
25
Change (1Y)
13
Growth (1Y)
108.33%
Revenue / Employee
n/a
Profits / Employee
-$4,736,418
Market Cap
91.87M
Employees Chart
RENB News
- 27 days ago - Renovaro Completes First Milestone Payment to Finalize Definitive Agreement with Predictive Oncology - GlobeNewsWire
- 4 weeks ago - Renovaro and BioSymetrics Announce Definitive Merger Agreement to Advance AI-Driven Biomarker Discovery and Precision Medicine - GlobeNewsWire
- 4 weeks ago - Renovaro Announces $15 million in Equity Committed - GlobeNewsWire
- 2 months ago - PREDICTIVE ONCOLOGY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Predictive Oncology Inc. - POAI - Business Wire
- 2 months ago - Renovaro Appoints Nathen Fuentes as Chief Financial Officer - GlobeNewsWire
- 2 months ago - Renovaro Issues Shareholder Letter and Provides Corporate Update - GlobeNewsWire
- 2 months ago - Renovaro to Acquire Predictive Oncology in All-Stock Transaction - GlobeNewsWire
- 3 months ago - Renovaro Inc. Appoints Maurice van Tilburg to Lead GEDi Cube BV - GlobeNewsWire